Newborn screening is a set of tests performed on nearly every baby born in the United States, typically within 24 to 48 hours after birth. It checks for serious genetic, metabolic, and other conditions that aren’t visible at birth but can cause major health problems if not caught early. The screening has three parts: a blood test from the baby’s heel, a hearing check, and a heart oxygen measurement.
The Three Parts of Newborn Screening
Each component of the screening targets a different category of health concern, and together they cast a wide net for conditions that benefit from early treatment.
The blood spot test (often called the “heel stick”) is the most extensive part. A healthcare provider makes a quick pinprick on your baby’s heel and collects a few drops of blood onto small circles on a special filter paper card. Once the spots dry, the card goes to a state public health laboratory for analysis. This single blood sample can screen for dozens of conditions, from metabolic disorders to hormone deficiencies to blood diseases.
The hearing screen uses one of two methods. One measures sounds produced by the inner ear in response to soft clicks played through a tiny earphone. The other records electrical activity along the hearing pathway from the inner ear to the brainstem. Both are painless and usually done while the baby sleeps. You’ll typically get results right away.
The pulse oximetry screen checks for critical congenital heart defects by measuring oxygen levels in your baby’s blood. A small sensor is placed on the right hand and one foot. The screen is considered a pass when oxygen saturation is 95% or higher in both locations with no more than a 3% difference between them. A reading below 90% in either spot is an automatic fail. Results come back immediately.
What Conditions It Detects
Newborn screening programs can test for up to 50 conditions. A federal advisory panel maintains the Recommended Uniform Screening Panel, or RUSP, which lists “core” conditions every state is encouraged to screen for and “secondary” conditions that may be identified during the process. The exact list varies by state because each state chooses which conditions to include, which laboratory methods to use, and what cutoff values to apply.
The conditions fall into a few broad categories:
- Metabolic disorders like phenylketonuria (PKU), where the body can’t properly break down a component of protein. Left untreated, PKU causes intellectual disability. Caught early, it’s managed with a modified diet.
- Endocrine disorders like congenital hypothyroidism, where the thyroid gland doesn’t produce enough hormone for normal growth and brain development. Daily medication started in the first weeks of life prevents developmental delays.
- Hemoglobin disorders like sickle cell disease, which affects red blood cells and can cause pain, infections, and organ damage. Early detection allows preventive care, including antibiotics to ward off life-threatening infections in infancy.
- Critical congenital heart defects picked up by pulse oximetry, which can require surgery or other intervention shortly after birth.
- Hearing loss, where early identification allows families to begin interventions like hearing aids or sign language during the critical window for language development.
About 3,000 newborns in the U.S. test positive for one of these serious disorders each year. For all of them, the central idea is the same: conditions that would cause severe harm if discovered months or years later can often be managed effectively, or even have their worst outcomes prevented entirely, when treatment starts in the first days or weeks of life.
How and When Results Arrive
Hearing and pulse oximetry results come back almost immediately, usually before you leave the hospital. The blood spot results take longer. The lab sends them to your baby’s healthcare provider (not directly to you) about five to seven days after birth. If everything looks normal, your provider may mention the results at your baby’s first well-child visit, or you may need to call and ask.
An “out-of-range” result on the blood test does not mean your baby has a condition. It means the screening detected something that needs a closer look. These initial screens are designed to be sensitive, catching every baby who might have a problem even if that means flagging some who don’t. Follow-up testing, often a repeat blood test or a more specific diagnostic test, will confirm or rule out the condition. If your baby fails the hearing screen, a follow-up screen is typically scheduled within two weeks of discharge. A failed pulse oximetry reading leads to additional testing right away in the hospital to determine why oxygen levels are low.
If a blood spot result comes back with a presumptive positive for a serious condition, the process moves quickly. Parents are typically contacted by phone within 24 to 48 hours of the lab result, with recommendations to see the baby’s doctor immediately and get a referral to a specialty treatment center. Family testing and genetic counseling may also be offered.
Why It Happens So Early
The 24-to-48-hour window exists for a reason. Some of the conditions on the screening panel cause irreversible damage within days if untreated. At the same time, the baby needs to have been feeding for long enough that certain metabolic markers show up in the blood. That narrow window after birth, before hospital discharge, hits the sweet spot for accurate detection and rapid intervention. Babies born outside a hospital, or those discharged before screening is complete, should be brought to a hospital or clinic within that same timeframe.
State Requirements and Parental Rights
Newborn screening is mandated by law in every U.S. state and territory under a legal principle called “parens patriae,” which gives the state authority to protect the health of children. In practice, this means screening happens automatically for virtually every baby born in the country.
Most states do allow parents to refuse screening on religious or philosophical grounds, though the process for opting out varies. Only Wyoming and the District of Columbia require signed parental permission before screening is conducted. In most other states, parents may not even realize screening has been performed or that they had the option to decline. The legal landscape reflects a strong public health consensus: the benefit of catching these conditions early is significant enough that screening is treated as a default rather than an opt-in choice.
What Screening Does Not Do
Newborn screening is not a diagnostic test. It identifies babies who are at higher risk for specific conditions and need further evaluation. A normal result is reassuring but doesn’t guarantee your baby is free of all genetic or metabolic conditions, especially those not on your state’s panel. Conversely, an abnormal result often turns out to be a false alarm after follow-up testing. The screening is a first step, designed to be cautious, and the confirmatory testing that follows is what provides a definitive answer.